• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

44.85 -0.15 (-0.33%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 224,108
Open 45.15
Bid (Size) 43.07 (100)
Ask (Size) 47.45 (100)
Prev. Close 45.00
Today's Range 44.16 - 45.30
52wk Range 23.23 - 50.79
Shares Outstanding 32,250,236
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Boston Legacy FC Announces Sensory Room Sponsorship with Collegium Pharmaceutical
Today 8:00 EST
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium to Report Fourth Quarter and Full-Year 2025 Financial Results on February 26, 2026
February 12, 2026
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire

Performance

YTD
-1.5%
-1.5%
1 Month
-1.4%
-1.4%
3 Month
-1.6%
-1.6%
6 Month
+15.7%
+15.7%
1 Year
+53.6%
+53.6%

More News

Read More
News headline image
1 Profitable Stock on Our Watchlist and 2 That Underwhelm
February 08, 2026
Via StockStory
COLLEGIUM PHARMACEUTICAL INC (NASDAQ:COLL) Presents a Classic Value Case with High Earnings and Low Valuation ↗
February 04, 2026
Via Chartmill
Collegium Pharmaceutical Inc (NASDAQ:COLL) Presents a Compelling Value Investment Case ↗
January 07, 2026
Via Chartmill
News headline image
Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference
January 15, 2026
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
Collegium Pharmaceutical EVP Sells COLL 17,600 Shares Amid Strong Close of 2025 ↗
January 14, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Small-Cap Stocks We’re Skeptical Of
January 13, 2026
Via StockStory
News headline image
Collegium Provides 2026 Financial Guidance and Business Update
January 08, 2026
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
3 Russell 2000 Stocks Walking a Fine Line
January 06, 2026
Via StockStory
News headline image
Collegium Announces the Closing of $980 Million Syndicated Credit Facility
December 30, 2025
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
News headline image
2 Reasons to Avoid COLL and 1 Stock to Buy Instead
December 28, 2025
Via StockStory
Topics Supply Chain
News headline image
3 Cash-Producing Stocks We Think Twice About
December 23, 2025
Via StockStory
News headline image
Collegium Pharmaceutical Inc (NASDAQ:COLL) Shows Strong Earnings Momentum and Bullish Technical Setup ↗
December 20, 2025
Via Chartmill
News headline image
3 Unpopular Stocks We Find Risky
December 18, 2025
Via StockStory
News headline image
Collegium Pharmaceutical Inc (NASDAQ:COLL) Fits the Minervini Growth Momentum Strategy ↗
December 18, 2025
Via Chartmill
News headline image
Branded Pharmaceuticals Stocks Q3 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL)
December 14, 2025
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
1 Growth Stock Set to Flourishand 2 Facing Challenges
December 11, 2025
Via StockStory
News headline image
1 Mooning Stock with Promising Prospects and 2 Facing Challenges
December 05, 2025
Via StockStory
News headline image
1 Small-Cap Stock with Exciting Potential and 2 We Avoid
November 23, 2025
Via StockStory
News headline image
Branded Pharmaceuticals Stocks Q3 Earnings: Eli Lilly (NYSE:LLY) Best of the Bunch
November 17, 2025
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Collegium Pharmaceutical Inc (NASDAQ:COLL) Shows High Growth Momentum with Strong Technicals ↗
November 13, 2025
Via Chartmill
News headline image
5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q3 Earnings Call
November 13, 2025
Via StockStory
Topics Earnings
News headline image
1 Safe-and-Steady Stock with Competitive Advantages and 2 We Brush Off
November 12, 2025
Via StockStory
News headline image
Collegium to Participate in Upcoming Investor Conferences
November 12, 2025
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Collegium Pharmaceutical, Inc. - Common Stock publicly traded?
Yes, Collegium Pharmaceutical, Inc. - Common Stock is publicly traded.
What exchange does Collegium Pharmaceutical, Inc. - Common Stock trade on?
Collegium Pharmaceutical, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock?
The ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock is COLL on the Nasdaq Stock Market
What is the current price of Collegium Pharmaceutical, Inc. - Common Stock?
The current price of Collegium Pharmaceutical, Inc. - Common Stock is 44.85
When was Collegium Pharmaceutical, Inc. - Common Stock last traded?
The last trade of Collegium Pharmaceutical, Inc. - Common Stock was at 02/23/26 04:00 PM ET
What is the market capitalization of Collegium Pharmaceutical, Inc. - Common Stock?
The market capitalization of Collegium Pharmaceutical, Inc. - Common Stock is 1.45B
How many shares of Collegium Pharmaceutical, Inc. - Common Stock are outstanding?
Collegium Pharmaceutical, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap